IPO

Biotech firm Tharimmune is now a Super Validator on the Canton Network, a bold move blending clinical research with institutional digital finance.

The organic kids' food brand is going public, targeting a $764M valuation. Can its rapid growth and clean-label mission overcome its significant losses?

Blue Moon Metals debuts on Nasdaq under 'BMM', appointing finance veteran Peter Madsen to its board to spearhead a major U.S. critical metals expansion.

Czechoslovak Group's record-breaking €3.8B IPO on Euronext Amsterdam sees shares soar, signaling a major geopolitical shift in investor sentiment.

Facing a Nasdaq delisting threat, K Wave Media bets on a risky mix of K-content IP and a massive Bitcoin treasury to save its $50M valuation.

The serial SPAC sponsor's latest blank-check firm signals strong investor faith, targeting high-growth AI and cloud sectors amid a recovering market.

With a new CFO experienced in U.S. capital markets, KNOREX signals a strategic shift to bolster finances and accelerate its global AI advertising platform.

With strong Q1 momentum, Standex faces a complex market. Its upcoming Q2 results will offer key insights into global manufacturing and corporate strategy.

As it advances its 'greenest gold mine' project toward a 2027 decision, Spanish Mountain Gold engages a 30-year veteran to bolster investor confidence.

Italian e-grocery leader Everli moves closer to a public listing via a SPAC merger, testing investor appetite in a rebounding but cautious market.

A new logistics tech giant, SKG, emerges from a three-way merger, eyeing a Nasdaq IPO and leveraging AI to disrupt global supply chains from Asia to the U.S.

With its group CEO now leading its chemical unit, Aspo signals a major shake-up. Is the profitable Telko business being prepped for an IPO?

With sales falling and debt rising, Swiss tech firm Feintool brings in Marc Hundsdorf, a CFO known for IPOs and refinancing, to steer its financial future.

As Embecta prepares its Q1 results, investors watch closely to see if its move beyond insulin can reverse recent revenue declines and reshape its future.

Praetorian Acquisition Corp.'s $220M IPO tests a recovering SPAC market with its sharp focus on transforming traditional industries through AI.

21shares launches its Dogecoin ETF on NASDAQ, marking a new chapter for the meme coin, but it enters a crowded field with significant investor risks.

Gradient Investments is democratizing access to exclusive assets like private equity. Learn how their new Private Wealth Series aims to change investing.

Known for its plant-based ethos, Laird Superfood is embracing dairy with a new whey protein coffee. Is this a strategic pivot or a new era of wellness?

Fusion energy pioneer General Fusion aims for a Nasdaq listing via a $1B SPAC deal, fueling the race to provide clean power for the AI revolution.

Boutique investment bank Brookline snags four senior pros, signaling a strategic deepening of its expertise in the competitive healthcare and SPAC sectors.